You just read:

Impax Announces FDA Approval and Launch of Additional Strengths of Generic Focalin XR® (Dexmethylphenidate Hydrochloride) Extended-Release Capsules CII

News provided by

Impax Laboratories, Inc.

Jul 05, 2017, 17:02 ET